Loading organizations...
Konishiyasu operates as a specialized wholesaler and distributor of a diverse portfolio of industrial materials. The company's core offering encompasses a wide range of chemical products, including inorganic chemicals, organic compounds, and various resins. Beyond chemicals, Konishiyasu also provides surface treatment materials, essential metals, and electronic materials, serving as a critical supply chain partner across multiple manufacturing and industrial sectors.
The enterprise was established in 1828 by Yasubei Konishi, who initiated the business in the Nihombashi area of Japan as a wholesaler of drugs, dyes, and raw materials. This early venture laid the groundwork for the company’s future in materials distribution. The founding insight centered on providing crucial raw components to support the developing industries of the era, a business model that has evolved but remains central to Konishiyasu’s operations.
Konishiyasu serves a broad base of industrial customers involved in domestic and international manufacturing. Its product range indicates engagement with clients in electronics, automotive, construction, and other material-intensive industries. The company's vision involves continually adapting its extensive product catalog and global distribution network to meet the evolving demands for specialized materials, aiming to be a consistent and comprehensive partner for industrial clients worldwide.
Konishiyasu has 1 tracked investment across 1 company. The latest tracked deal is $16.0M Series A in VLP Therapeutics in March 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2021 | VLP Therapeutics | $16.0M Series A | — | Backstage Capital, Pioneer Fund, Queensbridge Venture Partners, Thirty Five Ventures, Anthony Saleh, Haroon Mokhtarzada, Jason Robins, Jean Pigozzi, Shane Battier, Robert Hisaoka, Hiroyuki Misawa, RJ Fund, SK Impact Fund, Masayoshi Fujimoto |